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Abstract 
Introduction: in vitro drug sensitivity relies on the growth of plasmodium in the presence of the antimalarials. 
These fresh isolates brought in for assay from collection sites normally not near the laboratory require a medium 
to keep the parasites viable in order to produce results which are a representation of the field situation in terms of 
drug susceptibility. Since factors  such  as  mixed  infection  of  drug resistant and  sensitive  parasites occurring 
in most field isolates can  influence  drug  test  outcome because they have different drug susceptibilities, 
Method: This study validated the use of a formulated transport medium (TM) by assaying clones which have 
been culture adapted in the lab for 50% inhibitory concentrations (IC50) against four antimalarials using SYBR 
Green 1 in vitro assay. These clones (3D7 and W2) were revived and recultured for assay. Prior to subjecting 
them to drugs, they were exposed to 2ml formulated TM and the conventional EDTA anticoagulant in 5ml 
vacutainer tubes to act as control.Results: Similarity was detected with no significant difference (P >0.05) 
observed in the medians inhibitory concentration 50 (IC50) between samples in the EDTA anticoagulant and TM 
holds however, samples in EDTA generally had higher IC50 values.Conclusion: This study concludes that the 
formulated TM holds promise for future use,  
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Introduction 
In Kenya Malaria is still the leading cause of morbidity and mortality (Kenya Ministry of Public Health and 
Sanitation, 2009). The disease accounts for 30 percent of Kenya’s outpatient visits, 19 percent of hospital 
admissions, two to three percent of inpatient deaths, and is a leading cause of death among children under the 
age of five (Kenya Ministry of Public Health and Sanitation 2011). Specifically, in Western Kenya, 32% of all 
deaths are associated with Malaria, It causes 22% deaths among children with severe malaria, out of which 10% 
occur in hospitals and 13% outside hospitals within 8 weeks after admission. Also, treatment of malaria with 
chloroquine in the region was associated with 33% case fatality rate compared to 11% for children treated with 
more effective regime (Jane et al., 1996). A variety of drugs have been used to treat malaria in Kenya over the 
years, including quinine and related compounds such as chloroquine, antifolate combination drugs, antibiotics, 
and artemisinin compounds. Efforts to control the spread of the disease, however, are hampered by a growing 
trend of resistance to antimalarial medications. This is a great concern to the Kenyan government, whose goal is 
to decrease morbidity and mortality due to malaria by 30 percent by 2017 (Kenya Ministry of Public Health and 
Sanitation 2011). It is predicted that clinical infections and death will begin to increase due to rapid spread of 
drug resistance parasites (Hastings and Alessandro, 2000).  
In addition to resistance to antimalarial combination therapies, there is also a concern with Plasmodium 
mixed infections. A mixed infection is defined as an infection with more than one type of species or genotype of 
Plasmodium (Ferdig and Su, 2000). Other groups have noted that a number of malarial infections are 
heterogeneous in their composition (Lorenzetti et al., 2008). Mixed infections of different genotypes are highly 
prevalent in malaria-endemic areas, particularly in Africa and Southeast Asia (Kobbe et al., 2006). In fact, 
almost all infections occurring in nature are mixed. Although highly understudied, the implications of a mixed 
infection are profound. They can cause a relapse as a result of emergence of the resistant subpopulation of 
parasites after the sensitive subpopulation has been eradicated by drug therapy. The existence of a resistant  
population may be a result of both divergent  evolution,  where  parasites  have acquired  resistance mechanisms,  
and/or  two cohabitating parasites  when the individual  is infected  (Hyde, 2002).  This phenomenon has been 
observed in areas of malaria endemicity in Africa and Southeast Asia where the mixed-infection prevalence is as 
high as 30% (Mayxay et al., 2004). However, there has been conflicting evidence as to the true frequency of 
Plasmodium mixed infections (Richie, 1988). Furthermore, this problem is confounded by the inability to 
properly identify and differentiate Plasmodium mixed infections. This phenomenon is possibly due to the assay’s 
detection limit, where susceptibility of one population ceases to affect the profile of the other subpopulation, 
effectively masking the existence of that subpopulation. At this low parasite subpopulation level, dominance of a 
resistance mechanism may not be high enough in the population and may result in the appearance of only one 
phenotype. The reverse is also possible, where a large susceptible subpopulation may influence the apparent 
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phenotype of the whole population. Most naturally occurring malaria infections are composed of mixed 
subpopulations with different drug susceptibilities (Postigo et al., 1998). It is likely that mixed infections of both 
drug sensitive and resistant parasites in a patient will produce test readings not representative of a typical 
resistant or sensitive parasite. Thus, there is a need of using clones which have identified these drug resistant sub 
populations to prevent treatment failures, misidentification of a populations susceptibility profile (Zimmerman et 
al., 2004) and also in any evaluation procedure so as to provide accurate test results. 
 
Materials and methods 
Ethical consideration 
This study was approved by Jaramogi Oginga Odinga teaching and referral hospital Ethics and review committee 
(JOOTRH ERC). 
 
Sample preparation 
These are clones which were kept in liquid nitrogen and needed to be recultured for the experiment.  
First the isolates were removed from liquid nitrogen and indicated in the nitrogen freezer log sheet, and then the 
vials were left to thaw in the incubator. Once the content liquefied it was transferred aseptically in to a 15ml 
centrifuge tube noting the volume. Slowly 1/5volume of 12% solution Nacl was added while swirling the tube. It 
was allowed to stand at room temperature for 5 minutes. 9 volume of 1.6%Nacl solution was added to it and was 
centrifuged at 1500rpm for 3minutes. Supernatant was aspirated before another 9volume of 0.9%Nacl and 0.2% 
dextrose solution were added. This was mixed gently and centrifuged at 1500rpm for 3min, and then supernatant 
was aspirated. It was resuspended in culture medium by adding 4.5ml of 10% complete medium and 0.5ml of 
washed Rbcs for a 5ml culture. Then the culture was gassed and placed in an incubator at 370c to grow. Medium 
was being changed after every 48 hours while gassing the bottles.  Parasitaemia was checked three times weekly 
until the parasitaemia was 3-8%. Once the clones were ready for assay they were subjected to EDTA and the 
formulated TM for at least 6hours before they were washed in RPMI 1640 by centrifugation at 2500revolutions 
per minute for 3minutes for three consecutive times. samples with > 1% parasitemia were adjusted to1% 
parasitemia at 2% hematocrit using uninfected O+ erythrocytes, and those with ≤ 1% parasitemia were used 
unadjusted at 2% hematocrit. Transfer of parasite sample and antimalarial drug aliquots in complete RPMI 1640 
drug aliquots onto 96-well microculture plates and addition of lysis buffer after 72 hours incubation was done as 
previously described (Johnson et al., 2007).The plates were then placed at room temperature in the dark, for 5–
15 minutes.  Parasite replication inhibition was quantified and the IC50   for each drug calculated by an equation 
generating a sigmoidal concentration response curve (variable slope),  with  log  transformed drug  
concentrations on  the  X axis and  relative  fluorescent units  (RFUs) on  the Y axis (Graphpad Prism for 
Windows, version  5.0; Graphpad Software, Inc., San Diego, CA). (Bacon et al., 2007). 
 
Results 
Reference Plasmodium falciparum clones were assayed against the panel of antimalarials mentioned earlier.W2 
considered as chloroquine resistant, mefloquine sensitive and artemisinin sensitive  and 3D7 considered as 
chloroquine sensitive and mefloquine sensitive were used. Both clones gave successful assays in 95% of the 
plates in both EDTA and TM. Moderate RFU values of between 2000 to 4000 parasites were obtained by 
3D7clone while W2 had RFU values as high as 20,000 parasites. However, their curves converged into a 
discernible dose-response curve for IC50  determinations with most/all of the points of the 10 standard dilutions 
included in the sigmoidal curve, for most of the plates and recording a reliability value (r2) of almost 1 (to be 
specific 0.9999) as shown in an example in figure 1 below . For W2 clone the IC50 values in ng/ml for the 
samples in EDTA were all higher than their respective IC50 values in TM as shown in table 1 below .The same 
table continues to show that there weren’t any significant difference (P =0.3697 and 0.2084) in IC50 values in 
samples treated with LUM and DHA, but a high significant decrease (p<0.001) in IC50 values for samples 
subjected to ART and PPQ in TM was recorded. ART emerged to have the best activity with the least IC50 
values for samples in both EDTA and TM thus coinciding with the fact that W2 is artemisinin sensitive. On the 
other hand, LUM which is a recommended first line partner drug to ART in uncomplicated malarial treatment 
had the highest IC50 values of 32.61 and 29.32 in EDTA and TM respectively. As seen in figure 2 below, 
samples in both categories had the lowest individual IC50 of above 20ng/ml unlike other drugs whose minimum 
IC50 values were as low as 0.106 for DHA. 
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Figure 1: Example of sigmoidal curves generated by clones indicating RFU values against the 
concentration of a drug. 
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Figure 2: In vitro distribution of W2 IC50 values for samples in EDTA and TM 
in vitro activity of W2clone in EDTA and TM to antimalarials
A
R
T 
(E
)
LU
M
 (E
)
D
H
A
(E
)
P
PQ
 (E
)
A
R
T 
(T
) 
LU
M
 (T
)
D
H
A
 (T
)
P
PQ
 (T
)
0
20
40
60
80
100
120
140
ANTIMALARIALS
IC
5
0
 n
g
/m
l
 
The abbreviations E and T represent samples in EDTA and in Transport medium respectively. The 
medians IC50 (purple bars) with their interquartile ranges in black for all the drugs 
Table 1: Drug susceptibility testing of W2 reference clone in EDTA and TM against a panel of 
antimalarials 
Median IC50 in ng/ml for W2 reference clone 
samples in EDTA Samples in (Transport 
medium) TM 
P values of the medians using Mann 
- whitney test (P) 
 Drugs Median  Median   
1 Artemether 3.118 1.873 <0.001 
2 Lumefatrine 32.61 29.32 0.3697 
3 Diydroartemisinin 18.22 14.93 0.2084 
4 Piperaquine 18.93 11.41 <0.001 
Compared to W2, 3D7 clone showed reduced IC50 values for all the antimalarials for samples in EDTA 
and TM except for ART (which had an IC50 of 1.667 against 3.118 of W2). Besides, like W2, samples in EDTA 
had higher IC50 values than samples in TM as shown in table 2. However there wasn’t any significant difference 
(p=0.2549 and 0.3377) for samples exposed to ART and LUM in the two categories, while there was a high 
significant decrease (p=0.009 and 0.028) for samples in TM when they were treated with DHA and PPQ 
respectively.  Repeatedly, ART remained the most active drug with the least IC50 values while LUM retained its 
high IC50 values. Notably, in both clones, PPQ is the only drug with a persistent significant difference in IC50 
values in the two anticoagulants. PPQ and ART have close IC50 ranges between the minimum and the maximum 
values as shown in the figures 3 below. 
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Figure 3: In vitro distribution of 3D7 IC50 values for samples in EDTA and TM 
in vitro activity of 3D7clone in EDTA and TM to antimalarials
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The abbreviations E and T represent samples in EDTA and in Transport medium respectively. The 
medians IC50 (purple bars) with their interquartile ranges in black for all the drugs 
Table 2: Drug susceptibility testing of 3D7 reference clone in EDTA and TM against a panel of 
antimalarials 
Median IC50 in ng/ml for 3D7 reference clone 
samples in EDTA Samples in (Transport 
medium) TM 
P values of the medians using Mann 
- whitney test (P) 
 Drugs Median  Median   
1 Artemether 1.667 2.353 0.2549 
2 Lumefatrine 22.27 9.905 0.3377 
3 Diydroartemisinin 2.853 10.03 0.0098 
4 Piperaquine 7.181 13.0 0.028 
Using pearsons correlation coefficient, there was no correlation significance (P>0.05) between the two 
anticoagulants as indicated by their r values shown in table 4 and 5 below. However no significant difference 
(P>0.05) was observed between the individual activities of drugs as illustrated earlier in tables 3 and 4. 
Table 3: Correlations between EDTA and TM: results for W2 reference clone 
Sample in EDTA 
subjected to: 
Samples in TM 
subjected to: 
Correlation coefficient 
(r 
Probability 
P value 
ART ART -0.0110 0.9611 
LUM LUM -0.277 0.1901 
DHA DHA -0.2577 0.2727 
PPQ PPQ -0.1487 0.4983 
 
Table 4: Correlations between EDTA and TM: results for 3D7 reference clone 
Sample in EDTA 
subjected to: 
Samples in TM 
subjected to: 
Correlation coefficient 
(r) 
Probability 
P value 
ART ART 0.03275 0.8765 
LUM LUM 0.156 0.4771 
DHA DHA -0.021 0.9297 
PPQ PPQ -0.3025 0.1416 
The correlation coefficient was calculated by Pearson’s correlation coefficient of log IC50 values. 
Probability refers to the significance level of the test (p<0.05). ART- Artemether, LUM - Lumefantrine, DHA - 
Dihydroartemisinin and PPQ – Piperaquine 
 
Discussion 
Among the assays of the reference clones, in both anticoagulants, the IC50 range between the individual 
minimum and maximum values were small, this reflects reduced biological variability due to the absence of 
resistant and sensitive subpopulations of parasites, therefore, they were able to produce distinct IC50 dose 
response curves with most points of the standard dilutions include in the sigmoidal curve. This is in accordance 
with a study which argued that a pure parasite population either resistant or sensitive to a drug, will produce a 
curve with a sharp inhibition of parasite growth at a relatively narrow range of drug concentration, whereas a 
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mixed population with a minor resistant population of 10% or higher will produce a flattened curve or a double-
hump curve, reflecting two parasite populations with different IC50.(Liu et al., 2008). Nonetheless, it has been 
reported that among the field isolates, most naturally occurring malaria infections are composed of mixed 
subpopulations with different drug susceptibilities (Postigo et al.,1998, Zimmerman et al., 2004) bt a large 
susceptible or resistant subpopulation may influence the apparent phenotype  of the whole population (Co-em et 
al., 2009), a factor relevant to the current finding.On the other hand, W2 considered chloroquine resistant 
demonstrated an aspect of ‘resistance’ in all the drugs by having elevated IC50 values in all the drugs except for 
ART since its considered artemisinin sensitive.  
The high significant decrease in the medians for the W2 samples exposed to ART and PPQ and also a 
slight significant difference for DHA and PPQ in the 3D7 samples would have been affected by the selection of 
subpopulations in a clinical sample during initial culturing and isolation of the clones, since it has been reported 
that when clinical strains are culture adapted, they result in possible loss of the minor subpopulation and 
consequent misidentification of the population’s susceptibility profile (Basco and Lebras, 1994, Basco and 
Lebras, 1990). Also in line with a finding which was concerned that during culture adaptation there could be 
selection of a dorminant clone (Liu et al., 2008). Anyway, other studies have also shown that even with culture 
adaptation, the minor subpopulation is still detectable (Mbaisi et al., 2004). Additionally, the PPQ activities of 
3D7 and W2 in both anticoagulants obtained in the current study were in line with the PPQ activities of 8.3 and 
16 ng/ml in chloroquine sensitive and chloroquine resistant clones obtained by Vennerstrom et al., 1992. It was 
further observed that PPQ and LUM among the clones had the least activity, and this could have been attributed 
by the fact that the drugs are longer acting partner drugs to artemisinin derivatives with much longer half life, of 
3-4 days and 3-4 weeks for LUM and PPQ respectively (German and Aweeka, 2008) thus, in subsequent 
infections they are exposed to subtherapeutic concentrations of these drugs, facilitating selection of parasites. 
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